[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=b2de8eb9bb40b137161d76f5bc95967cee5f44cce17cb5a4f3b5a8fac2991726",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747672200,
      "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "id": 134615079,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=b2de8eb9bb40b137161d76f5bc95967cee5f44cce17cb5a4f3b5a8fac2991726"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Quality Value ETF Q1 2025 Commentary",
    "summary": "Hartford Quality Value ETF outperformed the Russell 1000 Value Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=32d7f8e3fad37beafac16093e7991b97881be0f20a5ebc8c13eff3326c47e8ed",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747668840,
      "headline": "Hartford Quality Value ETF Q1 2025 Commentary",
      "id": 134601056,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2194081197/image_2194081197.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Hartford Quality Value ETF outperformed the Russell 1000 Value Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=32d7f8e3fad37beafac16093e7991b97881be0f20a5ebc8c13eff3326c47e8ed"
    }
  },
  {
    "ts": null,
    "headline": "Pharmacies On Alert: Gilead Reports Pharmacies To State Boards Over Counterfeit Drug Purchases",
    "summary": "Independent pharmacies are facing a new level of scrutiny—and this time, it's coming directly from a major pharmaceutical manufacturer. Gilead Sciences, the maker of leading HIV medications such as...",
    "url": "https://finnhub.io/api/news?id=f93ba9b03ab88bc0dfb8d4ad640ca08a5591ab6ab80acf54cdd187831e9d339e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747649586,
      "headline": "Pharmacies On Alert: Gilead Reports Pharmacies To State Boards Over Counterfeit Drug Purchases",
      "id": 134578853,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Independent pharmacies are facing a new level of scrutiny—and this time, it's coming directly from a major pharmaceutical manufacturer. Gilead Sciences, the maker of leading HIV medications such as...",
      "url": "https://finnhub.io/api/news?id=f93ba9b03ab88bc0dfb8d4ad640ca08a5591ab6ab80acf54cdd187831e9d339e"
    }
  },
  {
    "ts": null,
    "headline": "Is TIGIT Still A Valid Target In Lung Cancer Patients? Arcus May Be Next To Fail",
    "summary": "Is TIGIT Still A Valid Target In Lung Cancer Patients? Arcus May Be Next To Fail",
    "url": "https://finnhub.io/api/news?id=753f6b0f679e303c7da4dcbc9ad03c56263b8b523b732f3e3f2a53d0faf5c8f6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747624069,
      "headline": "Is TIGIT Still A Valid Target In Lung Cancer Patients? Arcus May Be Next To Fail",
      "id": 134574990,
      "image": "",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=753f6b0f679e303c7da4dcbc9ad03c56263b8b523b732f3e3f2a53d0faf5c8f6"
    }
  }
]